Literature DB >> 1900264

Prognostic factors for surgically treated lung adenocarcinoma patients, with special reference to smoking habit.

T Sobue1, T Suzuki, I Fujimoto, O Doi, R Tateishi, T Sato.   

Abstract

Prognostic factors for lung adenocarcinoma patients who had been treated surgically at the Center for Adult Diseases, Osaka, in 1978-87 (N = 267) were analyzed in terms of year of operation, sex, age at operation, postsurgical stage, grade of differentiation, and smoking habit. Survival was improved for later year of operation (1983-87), younger age at operation, stage I or II, well or moderately differentiated adenocarcinoma, and nonsmoking status in univariate analysis. A proportional hazards model including the above variables showed that stage III and stage IV patients had 4.06 and 8.81 times higher risk of death compared to stage I and II patients. Poorly differentiated adenocarcinoma showed 2.01 times higher risk of death than well or moderately differentiated adenocarcinoma. Earlier year of operation and female status showed 1.70 and 1.82 times higher risk of death, respectively, as compared to each reference group. All these hazard ratios showed statistical significance. Current smokers who smoked 1,000 or more on the cigarette index showed 2.38 times higher risk of death than nonsmokers with statistical significance. This indicates that smoking is another independent prognostic factor for patients who undergo operations for adenocarcinoma of the lung.

Entities:  

Mesh:

Year:  1991        PMID: 1900264      PMCID: PMC5918210          DOI: 10.1111/j.1349-7006.1991.tb01742.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  16 in total

1.  Lymphocyte studies in asymptomatic cigarette smokers. A comparison between lung and peripheral blood.

Authors:  R P Daniele; J H Dauber; M D Altose; D T Rowlands; D J Gorenberg
Journal:  Am Rev Respir Dis       Date:  1977-12

2.  Recovery of immune system after cigarette smoking.

Authors:  W R Thomas; P G Holt; D Keast
Journal:  Nature       Date:  1974-03-22       Impact factor: 49.962

3.  Development of alterations in the primary immune response of mice by exposure to fresh cigarette smoke.

Authors:  W R Thomas; P G Holt; D Keast
Journal:  Int Arch Allergy Appl Immunol       Date:  1974

4.  Effect of smoking on the survival of patients with lung cancer.

Authors:  G Linden; J E Dunn; P H Hom; M Mann
Journal:  Cancer       Date:  1972-08       Impact factor: 6.860

5.  Assessment of lung cancer risk factors by histologic category.

Authors:  J H Lubin; W J Blot
Journal:  J Natl Cancer Inst       Date:  1984-08       Impact factor: 13.506

6.  Histopathologic prognostic factors in adenocarcinomas of the peripheral lung less than 2 cm in diameter.

Authors:  A Takise; T Kodama; Y Shimosato; S Watanabe; K Suemasu
Journal:  Cancer       Date:  1988-05-15       Impact factor: 6.860

7.  Smoking abstinence and small cell lung cancer survival. An association.

Authors:  A Johnston-Early; M H Cohen; J D Minna; L M Paxton; B E Fossieck; D C Ihde; P A Bunn; M J Matthews; R Makuch
Journal:  JAMA       Date:  1980-11-14       Impact factor: 56.272

8.  Comparison of survival in nonresected well differentiated and poorly differentiated adenocarcinoma of the lung.

Authors:  N Saijo; H Niitani; K Tominaga; K Eguchi; H Koketsu; T Fujino; S Ishikawa
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

9.  Association of adenocarcinoma of the lung with cigarette smoking by grade of differentiation and subtype.

Authors:  T Suzuki; T Sobue; I Fujimoto; O Doi; R Tateishi
Journal:  Cancer Res       Date:  1990-01-15       Impact factor: 12.701

10.  Smoking and lung cancer with special regard to type of smoking and type of cancer. A case-control study in north Sweden.

Authors:  L A Damber; L G Larsson
Journal:  Br J Cancer       Date:  1986-05       Impact factor: 7.640

View more
  8 in total

1.  Long-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer: comparing never smokers and current smokers.

Authors:  Robert A Meguid; Craig M Hooker; James Harris; Li Xu; William H Westra; J Timothy Sherwood; Marc Sussman; Stephen M Cattaneo; James Shin; Solange Cox; Joani Christensen; Yelena Prints; Nance Yuan; Jennifer Zhang; Stephen C Yang; Malcolm V Brock
Journal:  Chest       Date:  2010-05-27       Impact factor: 9.410

2.  Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancer.

Authors:  Yelena Y Janjigian; Kevin McDonnell; Mark G Kris; Ronglai Shen; Camelia S Sima; Peter B Bach; Naiyer A Rizvi; Gregory J Riely
Journal:  Cancer       Date:  2010-02-01       Impact factor: 6.860

3.  Smoking affects prognosis after lung cancer surgery.

Authors:  Hiroshige Nakamura; Tomohiro Haruki; Yoshin Adachi; Shinji Fujioka; Ken Miwa; Yuji Taniguchi
Journal:  Surg Today       Date:  2008-02-29       Impact factor: 2.549

4.  The Effects of smoking status and smoking history on patients with brain metastases from lung cancer.

Authors:  Rachel F Shenker; Emory R McTyre; Jimmy Ruiz; Kathryn E Weaver; Christina Cramer; Natalie K Alphonse-Sullivan; Michael Farris; William J Petty; Marcelo R Bonomi; Kounosuke Watabe; Adrian W Laxton; Stephen B Tatter; Graham W Warren; Michael D Chan
Journal:  Cancer Med       Date:  2017-04-12       Impact factor: 4.452

5.  Association between smoking and tumor progression in Japanese women with adenocarcinoma of the lung.

Authors:  I Sekine; K Nagai; S Tsugane; T Yokose; T Kodama; Y Nishiwaki; K Suzuki; T Kuriyama
Journal:  Jpn J Cancer Res       Date:  1999-02

6.  Efficacy of lung cancer screening; comparison of results from a case-control study and a survival analysis. The Japanese Lung Cancer Screening Research Group.

Authors:  T Sobue; T Suzuki; T Naruke
Journal:  Jpn J Cancer Res       Date:  1992-05

7.  Cyclooxygenase-2 (COX-2) mRNA expression levels in normal lung tissues and non-small cell lung cancers.

Authors:  M Ochiai; T Oguri; T Isobe; S Ishioka; M Yamakido
Journal:  Jpn J Cancer Res       Date:  1999-12

8.  Prognostic significance of p53 and ras gene abnormalities in lung adenocarcinoma patients with stage I disease after curative resection.

Authors:  T Isobe; K Hiyama; Y Yoshida; Y Fujiwara; M Yamakido
Journal:  Jpn J Cancer Res       Date:  1994-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.